Circulating Calprotectin as a Biomarker of COVID-19 Severity.
Michael MahlerPier-Luigi MeroniMaria InfantinoKatherine A BuhlerMarvin J FritzlerPublished in: Expert review of clinical immunology (2021)
Calprotectin represents a promising serological biomarker for the risk assessment of COVID-19 patients.